These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cellular action of nicardipine. Michel AD; Whiting RL Am J Cardiol; 1989 Oct; 64(15):3H-7H. PubMed ID: 2801573 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. Singh BN; Josephson MA Am Heart J; 1990 Feb; 119(2 Pt 2):427-34. PubMed ID: 1967896 [TBL] [Abstract][Full Text] [Related]
7. Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris. Lambert CR; Hill JA; Feldman RL; Pepine CJ Am J Cardiol; 1987 Sep; 60(7):471-6. PubMed ID: 3630928 [TBL] [Abstract][Full Text] [Related]
8. Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty. Feldman RL; MacDonald RG; Hill JA; Pepine CJ Am J Cardiol; 1987 Aug; 60(4):267-70. PubMed ID: 2441586 [TBL] [Abstract][Full Text] [Related]
9. Effects of nicardipine on myocardial function in vitro and in vivo. Lambert CR; Buss DD; Pepine CJ Circulation; 1990 Feb; 81(2 Suppl):III139-47. PubMed ID: 2297878 [TBL] [Abstract][Full Text] [Related]
10. Clevidipine: a review of its use in the management of acute hypertension. Deeks ED; Keating GM; Keam SJ Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440 [TBL] [Abstract][Full Text] [Related]
11. Nicardipine, a new calcium channel blocker: role for vascular selectivity. Pepine C Clin Cardiol; 1989 May; 12(5):240-6. PubMed ID: 2656020 [TBL] [Abstract][Full Text] [Related]
12. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine. Nishikibe M; Fukuroda T; Nakajima A Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamics of nicardipine in coronary artery disease. Visser CA; Koolen JJ; van Wezel H; Dunning AJ Am J Cardiol; 1987 Jun; 59(17):9J-12J. PubMed ID: 3300240 [TBL] [Abstract][Full Text] [Related]
14. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro. Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604 [TBL] [Abstract][Full Text] [Related]
15. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium. Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062 [TBL] [Abstract][Full Text] [Related]